|
131 |
The effect of Edaravone on acute ischemic stroke, large vessel occlusion, not treated with intravenous thrombolytic, and endovascular thrombectomy: a double-blind placebo-controlled trial
Enthalten in Naunyn-Schmiedeberg's archives of pharmacology 24.10.2025: 1-8
|
|
|
|
132 |
Anticoagulants: Evidence-Based Medicine, Not Always Ethical
Enthalten in Seminars in thrombosis and hemostasis 23.10.2025
|
|
|
|
133 |
Efficacy and Safety of Solriamfetol on Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea in China: A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial
Enthalten in CNS drugs 23.10.2025: 1-16
|
|
|
|
134 |
Topical lidocaine effectively mitigates radial pain, spasm, and sympathetic response following trans-radial coronary angiography: A randomized, double-blind, placebo-controlled clinical trial
Enthalten in Naunyn-Schmiedeberg's archives of pharmacology 22.10.2025: 1-11
|
|
|
|
135 |
Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled Studies
Enthalten in Thrombosis and haemostasis 21.10.2025
|
|
|
|
136 |
Estimating Treatment Effect for Target Population in Psychiatric Clinical Trials Using Placebo Lead-in Design
Enthalten in Therapeutic innovation & regulatory science 19.10.2025: 1-16
|
|
|
|
137 |
Lactobacillus Paracasei CNCM I 1572 is Better than Placebo in Preventing Acute Diverticulitis Occurrence (Revised Manuscript 661a120f-b910-4133-ab7e-4bd3e1713c96)
Enthalten in Probiotics and Antimicrobial Proteins 17.10.2025: 1-8
|
|
|
|
138 |
A combination typhoid and non-typhoidal Salmonella polysaccharide conjugate vaccine in healthy adults: a randomized, placebo-controlled phase 1 trial
Enthalten in Nature medicine 8.10.2025: 1-9
|
|
|
|
139 |
Effect of Oral Mirabegron on Catheter-Related Bladder Dysfunction After Elective Gynecological Surgery Under General Anesthesia: A Randomized, Placebo-Controlled, Double-Blind Study
Enthalten in International urogynecology journal 3.10.2025: 1-9
|
|
|
|
140 |
An Early Phase 2 Double-Blind, Placebo-Controlled Study of E6011, a Novel Anti-Fractalkine Antibody, in Patients with Crohn’s Disease
Enthalten in Inflammatory intestinal diseases Bd. 10, 2025, Nr. 1: 306-317. 12 S.
|
|
Administration
